Skip to main content
. 2026 Jan 20;6(1):100318. doi: 10.1016/j.ynirp.2026.100318

Table 3.

Distribution of Neurological Predictor Scale components and their contribution to total NPS scores.

Neurological Predictor Scale components Score contribution n (%)
Post surgical complicationsa
 Hearing impairment
 None 0 26 (72.22 %)
 Present 1 10 (27.78 %)
 Visual impairment
 None 0 19 (52.78 %)
 Present 1 17 (47.22 %)
 Motor deficits
 None 0 16 (44.44 %)
 Present 1 20 (55.56 %)
 Cranial nerve deficit
 None 0 30 (83.33 %)
 Present 1 6 (16.67 %)
Hydrocephalus requiring cerebrospinal fluid diversionb
 None 0 7 (19.44 %)
 Present 1 29 (80.56 %)
Surgery countc
 None 0 0 (0 %)
 Biopsy 1 3 (8.33 %)
 Neurosurgery 2 27 (75.00 %)
 More than one biopsy and surgery 3 6 (16.67 %)
Chemotherapy exposure
 None 0 17 (42.22 %)
 Received 1 19 (52.78 %)
Radiation exposured
 None 0 17 (42.22 %)
 Focal 1 0 (0 %)
 Whole brain or craniospinal 2 0 (0 %)
 Whole brain or craniospinal with boost 3 19 (52.78 %)

Note. Treatment burden was indexed using components of the Neurological Predictor Scale (NPS; Micklewright et al., 2008) and post-surgical indicators derived from medical record review.

a

Post-surgical complications include hearing impairment; visual impairment (diplopia or nystagmus); motor deficits (ataxia, dysmetria, or hemiparesis); and cranial nerve deficits (cranial nerve palsy) identified on neurological examination.

b

Hydrocephalus requiring cerebrospinal fluid diversion includes ventriculoperitoneal shunt placement or endoscopic third ventriculostomy.

c

Surgery count reflects the number of tumour-directed neurosurgical procedures (none, biopsy or biopsy only, one neurosurgery, more than one neurosurgery).

d

Radiation exposure was coded as none, focal radiation, whole-brain or craniospinal radiation, or whole-brain or craniospinal radiation with an additional focal boost.